pemetrexed Clinical Research Trials

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (3)

Phase 0 (1)
Phase 2 (1)
Phase 3 (1)

Interventional (2)

National Cancer Institute (NCI) (1)
National Hospital Organization Nagoya Medical Center (1)

No (3)

No (3)

Adult (18+) (3)
Pediatric (Under 18) (1)

I am/have/had

I am/have/hadmeasurable disease

I am/have/hadnon-small cell lung cancer

I am/have/hadlung cancer

I am/have/hadsmall cell lung cancer

I am/have/hadcancer

I am/have/hadmetastasis

I am/have/hadsquamous non-small cell lung cancer

I am/have/hadnon-squamous non-small cell lung cancer

I am/have/hadcarcinoma

I am/have/hadneutrophil count

I am/have/hadadjuvant therapy

I am/have/hadplatelet count

I am/have/hadlung carcinoma

I am/have/hadrecurrent non-small cell lung cancer

I am/have/hadchromosomal translocation

I am/have/hadantiretroviral therapy

I am/have/hadcisplatin/gemcitabine

I am/have/hadimmunohistochemistry

I am/have/hadimmunodeficiency

I am/have/hadsquamous cell carcinoma

added new label for I am/have/had

I am looking for

I am looking forpemetrexed

I am looking forcarboplatin

I am looking forcisplatin

I am looking forimmunomodulators

I am looking forpembrolizumab

I am looking forgemcitabine

I am looking formonoclonal antibodies

I am looking forpaclitaxel

I am looking formonoclonal protein

I am looking foradjuvant

added new label for I am looking for

Advanced Filters

Found 3 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Includes pre-screening
Phase 1
all
Recruiting

A081801 / RLUN20119 / ALCHEMIST-IO (ACCIO) / Yuhchyau Chen

Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor …

0 views
19 Feb, 2024
1 location

Phase 3
For Seniors
For adults
Recruiting in 1000s
Interventional Study
all
Recruiting

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer ALCHEMIST Chemo-IO Study

Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Drugs used in chemotherapy, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth …

cisplatin

antiretroviral therapy

egfr exon 19 deletion

monoclonal antibody therapy

stage iia lung squamous cell carcinoma ajcc v7

0 views
19 Feb, 2024

Phase 2
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Family Medicine
Recruiting

Pembrolizumab Plus Pemetrexed for Elderly Patients With Non-Sq NSCLC With PD-L1 < 50%: CJLSG1901

To evaluate the efficacy and safety of Pembrolizumab + Pemetrexed in elderly patients with non-squamous non-small cell lung cancer with Programmed cell death (PD) -ligand1 (L1) tumor proportion score (TPS) of less than 50%.

measurable disease

adjuvant therapy

metastasis

recurrent non-small cell lung cancer

squamous non-small cell lung cancer

0 views
19 Feb, 2024